The project on the development of new sensitive biomarks for early diagnosis and a better classification of neuroendocrine tumours is well established and running accord to plan. The first patients with NETs have been included in a unique clinical trial with an Oncolytic virus that is only killing the tumour cells and respect normal cells. The results so far look very promising. We expect to get specimens from 35 patients.
Colalboration with Jatakendeya 2024
Aware of the social discrimination and stigma towards people with disabilities and mental illness in Togo, the associations Jatakendeya and Miséricorde sans Frontière decided to create, in the year 2014,…
see project 
